Cardiovascular Systems Inc. (NASDAQ:CSII) shares saw strong trading volume on Wednesday . 336,733 shares traded hands during trading, an increase of 13% from the previous session’s volume of 297,993 shares.The stock last traded at $18.75 and had previously closed at $18.47.

A number of equities research analysts recently commented on the company. Zacks Investment Research cut Cardiovascular Systems from a “buy” rating to a “hold” rating in a research note on Tuesday. Needham & Company LLC reaffirmed a “buy” rating and set a $23.00 price objective (up from $20.00) on shares of Cardiovascular Systems in a research note on Wednesday, June 29th. Finally, Leerink Swann reissued a “market perform” rating and issued a $15.00 target price (up from $13.00) on shares of Cardiovascular Systems in a research note on Saturday, May 7th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $20.57.

The company’s market cap is $604.12 million. The stock has a 50 day moving average price of $17.34 and a 200 day moving average price of $13.19.

Cardiovascular Systems (NASDAQ:CSII) last released its quarterly earnings results on Wednesday, May 4th. The medical device company reported ($0.31) earnings per share for the quarter, topping the consensus estimate of ($0.54) by $0.23. The firm earned $44.50 million during the quarter, compared to the consensus estimate of $42.13 million. During the same period in the previous year, the company posted ($0.34) EPS. The company’s revenue for the quarter was down 5.3% compared to the same quarter last year. On average, analysts forecast that Cardiovascular Systems Inc. will post ($1.75) EPS for the current fiscal year.

An institutional investor recently raised its position in Cardiovascular Systems stock. Brown Advisory Inc. boosted its stake in Cardiovascular Systems Inc. (NASDAQ:CSII) by 2.1% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 342,446 shares of the medical device company’s stock after buying an additional 7,010 shares during the period. Brown Advisory Inc. owned approximately 1.05% of Cardiovascular Systems worth $5,178,000 at the end of the most recent reporting period.

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary arterial diseases. It has developed an orbital atherectomy technology for peripheral and coronary commercial applications. Its peripheral arterial disease systems are catheter-based platforms that treat plaque types in leg arteries both above and below the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.